---
title: "Wyeth Ltd(Merged) (WYETH) — Share Price, Financials & Analysis"
symbol: "WYETH"
company: "Wyeth Ltd(Merged)"
canonical: "https://tapetide.com/stocks/WYETH"
nse_symbol: "WYETH"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:58:52.211Z"
---

# Wyeth Ltd(Merged) (WYETH)

Canonical page: https://tapetide.com/stocks/WYETH

## Company

- **NSE Symbol:** WYETH
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** wyethindia.com

## About

Wyeth Limited is an India-based biopharmaceutical company. The company is engaged in manufacturing, marketing, trading and export of pharmaceuticals and consumer healthcare products.

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 26.1%
- Company has been maintaining a healthy dividend payout of 144%
- Company's working capital requirements have reduced from 27.3 days to 16.7 days

### Weaknesses

- Stock is trading at 9.14 times its book value

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 8% | -19% | -3% |
| revenue growth | 7% | 2% | 12% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 138 | 153 | 168 | 157 | 171 | 182 | 167 | 171 | 161 | 180 | 193 | 208 |
| Expenses | 110 | 102 | 119 | 120 | 140 | 138 | 142 | 152 | 141 | 141 | 155 | 161 |
| Operating Profit | 28 | 51 | 49 | 37 | 31 | 44 | 25 | 19 | 20 | 38 | 38 | 47 |
| OPM % | 20 | 33 | 29 | 24 | 18 | 24 | 15 | 11 | 12 | 21 | 20 | 23 |
| Other Income | 8 | 13 | 10 | 9 | 8 | 9 | 9 | 10 | 8 | 8 | 6 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 34 | 63 | 58 | 45 | 38 | 52 | 34 | 28 | 27 | 45 | 43 | 51 |
| Tax % | 28 | 31 | 33 | 33 | 33 | 32 | 35 | 35 | 35 | 34 | 34 | 35 |
| Net Profit | 25 | 44 | 39 | 30 | 26 | 35 | 22 | 18 | 17 | 30 | 28 | 34 |
| EPS in Rs | 10.84 | 19.23 | 17.15 | 13.33 | 11.33 | 15.5 | 9.77 | 8.1 | 7.69 | 13.17 | 12.54 | 14.78 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 8m | Mar 2011 16m | Mar 2012 | Mar 2013 | Mar 2014 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 286 | 285 | 329 | 382 | 286 | 640 | 588 | 678 | 679 | 742 |
| Expenses | 213 | 186 | 223 | 253 | 207 | 412 | 415 | 516 | 576 | 598 |
| Operating Profit | 73 | 99 | 106 | 129 | 79 | 228 | 173 | 162 | 103 | 143 |
| OPM % | 25 | 35 | 32 | 34 | 28 | 36 | 29 | 24 | 15 | 19 |
| Other Income | 18 | 19 | 19 | 21 | 10 | 18 | 39 | 35 | 34 | 26 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 9 | 6 | 3 | 3 | 3 |
| Profit before tax | 84 | 111 | 118 | 142 | 82 | 236 | 205 | 193 | 134 | 166 |
| Tax % | 19 | 17 | 31 | 30 | 28 | 30 | 29 | 33 | 34 | — |
| Net Profit | 68 | 92 | 81 | 100 | 59 | 165 | 145 | 130 | 88 | 109 |
| EPS in Rs | 29.83 | 40.69 | 35.89 | 43.91 | 25.99 | 72.81 | 63.74 | 57.3 | 38.73 | 48.18 |
| Dividend Payout % | 84 | 74 | 84 | 74 | 77 | 30 | 28 | 30 | 375 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 223 | 234 | 236 | 249 | 255 | 362 | 459 | 544 | 247 |
| Borrowings | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Other Liabilities | 106 | 122 | 132 | 158 | 124 | 112 | 165 | 223 | 232 |
| Total Liabilities | 354 | 381 | 393 | 432 | 404 | 499 | 649 | 792 | 504 |
| Fixed Assets | 47 | 43 | 39 | 38 | 31 | 26 | 24 | 24 | 24 |
| CWIP | 0 | 1 | 3 | 1 | 2 | 2 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 306 | 336 | 351 | 393 | 371 | 472 | 624 | 768 | 479 |
| Total Assets | 354 | 381 | 393 | 432 | 404 | 499 | 649 | 792 | 504 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 61 | 79 | 86 | 60 | 58 | 151 | 76 | 92 | 119 |
| Cash from Investing Activity | 11 | 14 | 13 | 14 | 10 | 12 | 31 | 32 | 29 |
| Cash from Financing Activity | -52 | -65 | -80 | -80 | -86 | -94 | -19 | -48 | -430 |
| Net Cash Flow | 20 | 28 | 18 | -6 | -18 | 69 | 89 | 76 | -282 |
| Free Cash Flow | 64 | 78 | 81 | 57 | 56 | 145 | 79 | 92 | 116 |
| CFO/OP | 88 | 99 | 110 | 83 | 93 | 94 | 81 | 103 | 163 |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 25 | 25 | 25 | 23 | 25 | 19 | 34 | 24 | 27 |
| Inventory Days | 168 | 198 | 139 | 177 | 228 | 128 | 207 | 247 | 179 |
| Days Payable | 97 | 104 | 120 | 165 | 171 | 109 | 139 | 188 | 202 |
| Cash Conversion Cycle | 97 | 118 | 44 | 36 | 82 | 39 | 102 | 83 | 4 |
| Working Capital Days | 4 | -9 | -20 | 6 | 45 | 27 | 38 | 27 | 17 |
| ROCE % | — | 43 | 45 | 54 | 30 | 72 | 46 | 37 | 32 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 7 / 4

### Moving Averages — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 58.54 | Buy |
| EMA (10) | 58.12 | Buy |
| SMA (20) | 57.6 | Buy |
| EMA (20) | 58.92 | Buy |
| SMA (50) | 65.97 | Sell |
| EMA (50) | 61.45 | Sell |
| SMA (100) | 60.06 | Sell |
| EMA (100) | 58.05 | Buy |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.05 | Neutral |
| MACD (12,26,9) | -1.52 | Buy |
| Stochastic (14,3,3) | 58.24 | Neutral |
| ADX (14) | 25.67 | Buy |
| Williams %R (14) | -24.1 | Neutral |
| ATR (14) | 2.98 | High Volatility |
| ROC (12) | 8.03 | Buy |
| Stoch RSI (14) | 84.33 | Sell |
| UO (7,14,28) | 46.08 | Neutral |

## Filings & Documents

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_WYETH_2011_2012_11072012112324.zip) |
| from nse | [Annual Report 2011 from nse](https://archives.nseindia.com/annual_reports/AR_WYETH_2011_2011_27062011130505.zip) |
| from nse | [Annual Report 2010 from nse](https://archives.nseindia.com/annual_reports/AR_WYETH_2010_2010_27062011130505.zip) |
| from nse | [Annual Report 2009 from nse](https://archives.nseindia.com/annual_reports/AR_WYETH_2009_2009_18082010121500.zip) |
| from bse | [Annual Report 2014 from bse](https://www.bseindia.com/bseplus/AnnualReport/500095/5000950314.pdf) |
| from bse | [Annual Report 2014 from bse](http://www.bseindia.com/bseplus/AnnualReport/500095/5000950314.pdf) |
| from bse | [Annual Report 2013 from bse](https://www.bseindia.com/bseplus/AnnualReport/500095/5000950313.pdf) |
| from bse | [Annual Report 2012 from bse](https://www.bseindia.com/bseplus/AnnualReport/500095/5000950312.pdf) |
| from bse | [Annual Report 2011 from bse](https://www.bseindia.com/bseplus/AnnualReport/500095/5000950311.pdf) |
| from bse | [Annual Report 2009 from bse](https://www.bseindia.com/HIS_ANN_RPT/HISTANNR/2009/WYETH_LTD-500095-MARCH-2009.PDF) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:58:52.211Z.